Finding your first job can be a challenge for early-career clinicians. Luckily, Endocrine News talked to some seasoned pros with advice on how to find a setting that appeals to you, your family, and your professional goals. What’s the best way to find a clinical position as an early-career endocrinologist? Flexibility, focus, and knowing what...
Endocrine News gets the patient and physician perspective on thyroid eye disease. Patients discuss how it has affected their lives and clinicians explain the limited treatment choices. However, new options may be available soon. Christine Gustafson, of Monterey, Calif., swam a mile a day and biked everywhere she went. When she noticed her heart was...
It helps to be able to “talk the talk” and make the business case as well as the clinical case for new expenses. Healthcare is one of the sectors where technical innovation is taking place at a break-neck pace. A practice that is slow to adapt will be slow to catch up to an everchanging...
E-Consults: Increasing the Efficiency and Efficacy of the Referral Process
One useful piece of innovation that can more effectively enhance a clinical setting is the use of E-consults, which has shown an increase in satisfaction by both patients and clinicians alike. As clinicians continue to strive for more innovative ways to “take back their practices,” one method that proved remarkably successful in the San Francisco...
In his session at ENDO 2019, Jeffrey Boord, MD, MPH, proposed the use of clinical pharmacists in primary care practices to help manage patients as well as overcome clinical inertia. Clinical inertia is one of the issues that can be a deterrence to optimal care for diabetes patients in a primary care setting, which, according...
In Living Color: Extending Your Practice’s Reach Via Telehealth
The advent of smart phones has enabled patients to avoid lengthy travel and made languishing in waiting rooms a thing of the past as telehealth has become more and more common in endocrinology practices. Telehealth can help manage the kind of chronic conditions, such as hypothyroidism or diabetes, that are considered hallmarks of endocrinology. Such...
FDA Approves First Ready-to-Use Stable Liquid Glucagon for Severe Hypoglycemia
The U.S. Food and Drug Administration (FDA) recently approved a ready-to-use, room-temperature stable liquid glucagon for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages 2 years and above. Xeris Pharmaceuticals is marketing this new glucagon injection as GVOKE. GVOKE is the first glucagon product approved that can be administered via...
The U.S. Food and Drug Administration last month approved semaglutide oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, along with diet and exercise. This is the first glucagon-like peptide (GLP-1) receptor protein treatment approved for use in the United States that does not need to be injected. GLP-1...